<< Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs | Alvine Pharmaceuticals raises funds for Phase 2a clinical trial of its lead compound ALV003 >>

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Published on September 15, 2009 at 8:44 AM · No Comments

Hyperion Therapeutics today announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle disorders (UCD). The study will evaluate the safety, tolerability, and ammonia control of glycerol phenylbutyrate compared to BUPHENYL^® (sodium phenylbutyrate). The 2-3 week trial will enroll ten children currently treated with sodium phenylbutyrate for their UCD and will be followed by a one year open-label safety extension. The pivotal efficacy study in adult UCD patients will be conducted in parallel beginning later this year.

www.hyperiontx.com

e3bc0ce1-5fbf-4b7f-87c5-2015f28bec79|0|.0

Posted in: Child Health News | Drug Trial News

Tags: Amenorrhea, Body Odor, Brain, Congestive Heart Failure, Edema, Gastroenterology, Haloperidol, Heart Failure, Hepatology, Hypersensitivity, Metabolism, Valproic Acid

Related posts

Study evaluates availability of information about cosmetic ingredients for celiac patientsThe lack of readily available information about cosmetic ingredients may cause patients with celiac ...
Antioxidants may help treat infertility problems in both women and menA growing body of evidence suggests that antioxidants may have significant value in addressing infer...
Amgen appeals EMA CHMP negative opinion on Vectibix-chemotherapy combination for wild-type KRAS mCRCAmgen announced today that it has submitted a request to the European Medicines Agency (EMA) for a r...
Takeda completes settlements in patent litigation over generic ACTOS, ACTOplus met, and duetact ANDAsTakeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and its wholly-owned su...
AASLD, TFAH report calls for action to help identify Americans living with HBV, HCVThe American Association for the Study of Liver Diseases and the Trust for America's Health issued a...
Study examines long-term effect of TBI on women's reproductive healthAfter a brain injury, women often ask how the injury will affect their fertility, pregnancy and post...
New study indicates pine bark may reduce progressing advanced stages of diabetic retinopathyAccording to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with ...
IPIT uses Affymetrix’s DMET Plus biomarker panel to expand the PGENIAffymetrix, Inc. announced today that the Institute for Pharmacogenomics and Individualized Therapy ...
Study reveals that brain damage in amateur boxers can be detected by a blood testA blood test can now be used to detect brain damage in amateur boxers. Deterioration of nerve cells ...
Valproic acid (Depakote) may help treat lupusA common anti-seizure drug may be effective against certain conditions associated with lupus, accord...
Study of the effects of aripiprazole, olanzapine, quetiapine and risperidone, in elderly patients with dementiaSome newer antipsychotic medications may be associated with a small increased risk of death when use...
Smell may play a big role in selecting your potential mateYour nose, whether big or small, male or female, heterosexual or homosexual, may play a big role in ...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.